JP2005519905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519905A5 JP2005519905A5 JP2003561574A JP2003561574A JP2005519905A5 JP 2005519905 A5 JP2005519905 A5 JP 2005519905A5 JP 2003561574 A JP2003561574 A JP 2003561574A JP 2003561574 A JP2003561574 A JP 2003561574A JP 2005519905 A5 JP2005519905 A5 JP 2005519905A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- pharmaceutical formulation
- tucaresol
- mpl
- cpg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201736.6A GB0201736D0 (en) | 2002-01-25 | 2002-01-25 | DNA dosage forms |
| GB0201735A GB0201735D0 (en) | 2002-01-25 | 2002-01-25 | DNA dosage forms |
| PCT/GB2003/000336 WO2003061629A2 (en) | 2002-01-25 | 2003-01-23 | Dna dosage forms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519905A JP2005519905A (ja) | 2005-07-07 |
| JP2005519905A5 true JP2005519905A5 (https=) | 2006-02-09 |
Family
ID=27614803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003561574A Pending JP2005519905A (ja) | 2002-01-25 | 2003-01-23 | Ｄｎａの製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20050085434A1 (https=) |
| EP (1) | EP1467711B1 (https=) |
| JP (1) | JP2005519905A (https=) |
| AT (1) | ATE357219T1 (https=) |
| CA (1) | CA2473717A1 (https=) |
| DE (1) | DE60312645T2 (https=) |
| ES (1) | ES2285087T3 (https=) |
| WO (1) | WO2003061629A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ538628A (en) * | 2002-08-12 | 2008-06-30 | Dynavax Tech Corp | Immunomodulatory compositions, methods of making, and methods of use thereof |
| AU2002951692A0 (en) * | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
| GB0423681D0 (en) * | 2004-10-26 | 2004-11-24 | Sec Dep For Environment Food & | Vaccine and nucleic acids |
| EP1916002B1 (en) * | 2005-08-02 | 2014-03-05 | Santen Pharmaceutical Co., Ltd. | Method for prevention of degradation of thermally unstable substance |
| JP5252787B2 (ja) * | 2005-08-02 | 2013-07-31 | 参天製薬株式会社 | 熱的に不安定な薬物の分解抑制方法 |
| US8512679B2 (en) | 2011-03-04 | 2013-08-20 | Elwha Llc | Glassy compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE235558T1 (de) * | 1989-06-26 | 2003-04-15 | Powderject Vaccines Inc | Transformation von tierischen somatischen zellen mittels partikeln |
| DK28792D0 (da) * | 1992-03-04 | 1992-03-04 | Novo Nordisk As | Nyt enzym |
| JPH08510639A (ja) * | 1993-04-19 | 1996-11-12 | メディソーブ・テクノロジーズ・インターナショナル・リミテッド・パートナーシップ | 細胞取込みと遺伝子発現の促進と標的化をもたらす接合体と核酸のカプセル化 |
| CA2158733C (en) * | 1994-01-21 | 2007-01-16 | Dennis E. Mccabe | Gas driven gene delivery instrument |
| ES2208687T3 (es) * | 1994-08-04 | 2004-06-16 | Elan Drug Delivery Limited | Sistema de administracion de sustancias solidas para la liberacion controlada de moleculas incorporadas en tales sustancias y procedimientos para la fabricacion de tales sistemas. |
| US6290991B1 (en) * | 1994-12-02 | 2001-09-18 | Quandrant Holdings Cambridge Limited | Solid dose delivery vehicle and methods of making same |
| EP0906110B1 (en) * | 1996-04-26 | 2004-12-22 | Merck & Co., Inc. | Dna vaccine formulations |
-
2003
- 2003-01-23 EP EP03700947A patent/EP1467711B1/en not_active Expired - Lifetime
- 2003-01-23 CA CA002473717A patent/CA2473717A1/en not_active Abandoned
- 2003-01-23 US US10/502,290 patent/US20050085434A1/en not_active Abandoned
- 2003-01-23 AT AT03700947T patent/ATE357219T1/de not_active IP Right Cessation
- 2003-01-23 ES ES03700947T patent/ES2285087T3/es not_active Expired - Lifetime
- 2003-01-23 WO PCT/GB2003/000336 patent/WO2003061629A2/en not_active Ceased
- 2003-01-23 JP JP2003561574A patent/JP2005519905A/ja active Pending
- 2003-01-23 DE DE60312645T patent/DE60312645T2/de not_active Expired - Fee Related
-
2007
- 2007-06-01 US US11/756,817 patent/US20080095854A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004523498A5 (https=) | ||
| JP2004532810A5 (https=) | ||
| JP2004529078A5 (https=) | ||
| JP2003520232A5 (https=) | ||
| JP2001194792A5 (https=) | ||
| JP2002506648A5 (https=) | ||
| RU2489151C3 (ru) | Фармацевтическая комбинация, содержащая ингибитор sglt2 | |
| DE602004010493D1 (de) | Kaugummi in der form von mehrschichttabletten | |
| DE60038304D1 (de) | Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen | |
| JP2001131087A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| JP2005538045A5 (https=) | ||
| JP2005519905A5 (https=) | ||
| JP2005511619A5 (https=) | ||
| ITRM20030363A1 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse. | |
| JP2002022755A5 (https=) | ||
| JP2006505391A5 (https=) | ||
| JP2000141643A5 (https=) | ||
| EP1476174A4 (en) | PHARMACEUTICAL PREPARATION WITH PROPHYLACTIC EFFECTS ON LAMIVUDINE-RELATED REACTIONS AND PHARMACORESISTANCE, AND METHODS OF USING THE SAME | |
| JP2005536763A5 (https=) | ||
| JP2004526429A5 (https=) | ||
| JP2007513894A5 (ja) | Ｃｈｐ−ゲムシタビン複合剤および抗腫瘍剤、特に抗転移剤としてのその使用 | |
| JP2003119141A5 (https=) | ||
| JP2005298393A5 (https=) | ||
| IT1318522B1 (it) | Procedimento per la preparazione di agglomerati stabilizzati da ceneredi lolla e paglia di riso. |